EPIS B — Episurf Medical AB Cashflow Statement
0.000.00%
- SEK166.62m
- SEK136.72m
- SEK10.60m
Annual cashflow statement for Episurf Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -68.9 | -63.4 | -69.4 | -77 | -96.7 |
Depreciation | |||||
Non-Cash Items | 0.1 | 1.4 | 3.3 | -0.2 | 0.7 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.3 | 0.4 | -1 | 0.3 | 2.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -59.1 | -54 | -59.7 | -69.5 | -84.9 |
Capital Expenditures | -5.5 | -4.6 | -7 | -11.3 | -9.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | -0.5 | 0.5 | 0.1 | — |
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5.5 | -5.1 | -6.5 | -11.2 | -9.5 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 61.6 | 189 | 149 | -1.9 | -3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3 | 130 | 83 | -82.6 | -97.4 |